The Triggering Receptor Expressed on Myeloid cells-1: A new player during acute myocardial infarction

Abstract : Following myocardial ischemia, an intense activation of the immune system occurs that leads to inflammatory cytokines and chemokines production and to the recruitment of neutrophils and mononuclear cells in the infarcted area. Although pro-inflammatory signals initiate the cellular events necessary for scar formation, excessive and prolonged inflammation promotes deleterious cardiac remodeling and dysfunction. The triggering receptor expressed on myeloid cells-1 (TREM-1) is a highly conserved immune-receptor expressed by neutrophils and monocytes that acts as an amplifier of the innate immune response. Blockade of TREM-1 activation protects from hyper-responsiveness and death during severe infections. Here we review the role of TREM-1 in orchestrating the inflammatory response that follows MI. TREM-1 deletion (Trem-1-/-) or modulation by the use of a short inhibitory peptide (LR12) dampens myocardial inflammation, limits leukocyte recruitment, and improves heart function and survival in mice or pigs. Moreover, the soluble form of TREM-1 (sTREM-1) is found in the plasma of patients suffering from an acute MI and its concentration is an independent predictor of death. This suggests that TREM-1 may constitute a new therapeutic target during acute MI.
Complete list of metadatas

https://hal.univ-lorraine.fr/hal-01758752
Contributor : Dcac Ul <>
Submitted on : Wednesday, April 4, 2018 - 5:24:50 PM
Last modification on : Thursday, April 5, 2018 - 1:31:22 AM

Identifiers

Collections

Citation

Jérémie Lemarié, Amir Boufenzer, Marc Derive, Sébastien Gibot. The Triggering Receptor Expressed on Myeloid cells-1: A new player during acute myocardial infarction. Pharmacological Research, Elsevier, 2015, 100, pp.261 - 265. ⟨10.1016/j.phrs.2015.07.027⟩. ⟨hal-01758752⟩

Share

Metrics

Record views

45